Two major international studies have delivered the strongest evidence to date on which noninvasive tests can accurately diagnose and measure the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form, MASH, reducing reliance on liver biopsy.
Related Posts
‘Unique K’ Didn’t Retire When Spravato Showed Up
A former Cornell student determined as Jane Doe affirms she was consuming alcohol, provided ketamine, and sexually assaulted at a fraternity home in October 2024 […]
The Future is Unwritten – Healing Arts Symposium
Symposium presented in partnership with the World Health Organization and The Metropolitan Museum of Art is a “cultural call to action” to invest in the […]
California redwoods are struggling in the heat — and it’s not clear how much damage is being done
When temperatures spike, California redwoods slow down photosynthesis, new research has found. This finding has serious implications for the long-term survival of the iconic trees […]